Relief Mental Health Alternative Treatment Options

Table of Contents

• Why People Look for Alternative Treatment Options
• Depression Treatment Options Compared: Therapy, Medication, and TMS
  • Psychotherapy and Talk Therapy
  • Psychiatric Medication and Esketamine
  • Transcranial Magnetic Stimulation (TMS)
• Alternatives to Medication for Depression: What the Evidence Shows
• Affordable Mental Health Care: Insurance, Cost, and Access
• How to Get Psychiatric Help for a Family Member
• Eligibility, Assessment, and Referral Pathways
  • Who typically qualifies for advanced treatment
  • What an initial assessment actually involves
  • Referral pathways: three realistic routes
  • Access and logistics to ask about up front
• Risks, Side Effects, and What to Ask Before You Start
• Conclusion
• Frequently Asked Questions

Last Updated: October 18, 2026

Why People Look for Alternative Treatment Options

Adults who have tried two or more antidepressants without relief often start searching for something different. That search is reasonable. Treatment-resistant depression is common enough that clinicians now treat "what next" as a standard question rather than an exception, and the menu of alternative treatment options has widened considerably in recent years.

At Trust and Care Mental Health Inc, we see this pattern constantly: people arrive exhausted, having cycled through medications that either didn't work or came with side effects they couldn't tolerate. They want to know what else exists.

Three forces drive the search. First, medication doesn't work for everyone. Second, side effects push people to look for non-pharmacological treatment. Third, access and cost shape what's realistic.

Depression Treatment Options Compared: Therapy, Medication, and TMS

The best-supported depression treatment options fall into three broad categories: psychotherapy, psychiatric medication, and neuromodulation such as TMS. Most people benefit from combining at least two.

Psychotherapy and Talk Therapy

Psychotherapy is structured conversation with a trained clinician aimed at changing thought and behavior patterns. Cognitive behavioral therapy (CBT) and dialectical behavior therapy (DBT) are the most studied forms, with acceptance and commitment therapy (ACT) and eye movement desensitization and reprocessing (EMDR) used for specific presentations such as trauma. Group counseling and family therapy add social support. The American Psychological Association's treatment guidelines describe these as first-line options for mild to moderate depression.

Psychiatric Medication and Esketamine

Antidepressants remain the standard pharmacological route, prescribed and managed by a psychiatric provider. For people who haven't responded to multiple trials, esketamine nasal spray (Spravato) is an FDA-approved option that must be given in a certified, monitored clinical setting because of risks including dissociation and blood pressure changes.

Transcranial Magnetic Stimulation (TMS)

TMS therapy uses magnetic pulses to stimulate underactive brain regions. It is non-invasive, requires no anesthesia, and is typically delivered in a series of outpatient sessions. The National Institute of Mental Health's overview of brain stimulation therapies positions TMS as an evidence-based option for depression that hasn't responded to medication.

Alternatives to Medication for Depression: What the Evidence Shows

"Alternative to medication" is not one category. It is at least four, and the evidence behind each is very different.

Why the grading matters. A person with mild-to-moderate depression and no trauma history has a genuinely different best-first option than someone with recurrent depression who relapses every time medication is tapered, or someone whose depression is downstream of untreated PTSD.

The adjunct-versus-replacement distinction. Yoga, meditation, and mindfulness programs have real but modest evidence as additions to therapy or medication. Presenting them as replacements for evidence-based care in moderate to severe depression overstates what the trials show.

Affordable Mental Health Care: Insurance, Cost, and Access

Affordable mental health care depends on three levers: insurance coverage, plan networks, and care setting. Most commercial plans and Medicare cover psychotherapy and psychiatric medication management, though copays and deductibles vary widely. Coverage for esketamine and TMS is more variable and often requires prior authorization and documentation that other treatments failed.

Ask providers directly for a cost estimate before your first visit. For general guidance on what plans must cover, the Centers for Medicare & Medicaid Services publishes plan information, and the Substance Abuse and Mental Health Services Administration offers resources for finding affordable care. We recommend asking three questions: Is this provider in network? What will I owe per visit? Does this treatment need prior authorization?

Make your appointment today →

How to Get Psychiatric Help for a Family Member

Getting psychiatric help for a family member works best when you frame it as concern, not diagnosis. Start with a specific observation ("I've noticed you've seemed withdrawn for weeks") and offer to help with the practical steps: finding a provider, checking insurance, or making the first call.

If a relative is in immediate danger, contact emergency services. For ongoing support, family therapy can bring everyone into the process. When the person resists, a primary care physician is often the least threatening entry point.

Eligibility, Assessment, and Referral Pathways

Most people never get a clear answer to the practical question: how do I actually find out if I qualify, and what happens first? This section walks through the pathway step by step, the part of the decision that general explainers leave out.

Who typically qualifies for advanced treatment

Eligibility for advanced options such as esketamine or TMS generally rests on a documented history of inadequate response to prior antidepressants. In practice, clinicians look for two or more adequate medication trials, adequate meaning the right dose for a long enough period, along with a current diagnosis and a clear record of what was tried and why it stopped. Some patients qualify after fewer trials if side effects made medication intolerable; others need a fuller history. A prior diagnosis alone is not enough, and a self-reported history without records often slows the process.

What an initial assessment actually involves

A first evaluation for advanced treatment is more structured than a standard therapy intake. Expect:

• A diagnostic interview to confirm the current diagnosis and screen for conditions that change the treatment plan, such as bipolar disorder, substance use, or untreated trauma.
• A medication history review, every antidepressant tried, the dose, the duration, and the reason it was stopped. Bring pharmacy records or ask your prescriber for a summary.
• Contraindication screening. For TMS, this includes screening for metal implants near the head, seizure history, and certain medical devices. For esketamine, it includes blood pressure history and cardiovascular risk.
• Symptom and functioning measures so progress can be tracked objectively rather than by memory.
• A conversation about goals, logistics, and cost, how many visits per week, how long the course runs, and what insurance will cover.

Referral pathways: three realistic routes

1. Primary care referral. A primary care provider can refer directly and is often the fastest route because they already hold the medication history. Ask them to send records, not just a name.
2. Self-referral. Many specialty clinics accept self-referrals and will request records from prior providers on your behalf. This route works well for people who have moved or changed providers and no longer have a single coordinating clinician.
3. Treatment-only partnership. Some practices provide the advanced treatment only and return the patient to their existing clinician for ongoing care. This keeps the long-term relationship intact and is often the preferred arrangement for people already established with a therapist or psychiatrist.

Access and logistics to ask about up front

• In-person versus virtual. Psychotherapy and medication management are widely available by telehealth; TMS and esketamine require in-person, monitored visits.
• Frequency and course length. TMS is typically delivered in a series of outpatient sessions over several weeks; esketamine involves supervised induction visits followed by maintenance. Ask how many visits per week and how long the full course runs before you commit.
• Wait times and geographic availability. Advanced treatment capacity varies widely by region. Ask about current wait times and whether the clinic has satellite locations.
• Records and prior authorization. Most advanced treatments require prior authorization, and the clinic usually handles the paperwork, but only if you supply the medication history early.

Risks, Side Effects, and What to Ask Before You Start

Every treatment carries trade-offs. Psychotherapy is low-risk but takes time. Antidepressants can cause nausea, sleep changes, and sexual side effects. Esketamine can cause dissociation and temporary blood pressure increases, which is why monitoring matters. TMS can cause scalp discomfort and headaches.

Before starting, ask: What are the known risks? How will I be monitored? What happens if it doesn't work? What is the plan if side effects appear? Shared decision-making with a qualified clinician is essential. Nothing here replaces an individual consultation.

Conclusion

Finding the right treatment after failed medication trials is hard, and the options can feel overwhelming. Trust and Care Mental Health Inc offers specialized care for treatment-resistant depression, including FDA-approved Spravato esketamine nasal spray in a monitored clinical setting, comprehensive services for children, adults, and older adults, and treatment-only options for referring providers. Make your appointment today and take the next step toward improved emotional well-being.